KPTI - Karyopharm spikes on cancelation of presentation at SVB Leerink conference

Karyopharm (KPTI +16.3%) shares surged on Friday on the news that the company had canceled its participation at the Annual SVB Leerink Global Healthcare Conference. Last week, the commercial stage biotech company announced that its Chief Executive Officer Richard Paulson would take part in a fireside chat at the virtual event scheduled for today. However, on a phone call, SVB Leerink analyst Jonathan Chang confirmed its cancellation, according to Bloomberg. According to CEO Paulson, the cancellation was made due to scheduling difficulties. Karyopharm (NASDAQ:KPTI) has added more than ~86% in this year alone, and the company has been considered a potential M&A target in the past.

For further details see:

Karyopharm spikes on cancelation of presentation at SVB Leerink conference